Table 2.
Diagnosis | Patients | En bloc | R0 | |
Esophagus | SMT | 5 | 5 (100.0) | 3 (60.0) |
GIST | 1 | 1 (100.0) | 1 (100.0) | |
Leiomyoma | 4 | 4 (100.0) | 2 (50.0) | |
Non-SMT | 9 | 9 (100.0) | 6 (66.7) | |
Early cancer/HGD | 6 | 6 (100.0) | 3 (50.0) | |
Neoplasia grade min/med | 3 | 3 (100.0) | 3 (100.0) | |
Stomach | SMT | 35 | 34 (97.1)a | 27 (77.1) |
GIST | 18 | 18 (100.0) | 16 (88.9) | |
Leiomyoma | 6 | 5 (83.3) | 3 (50.0) | |
Other | 11 | 11 (100.0) | 8 (72.7) | |
Non-SMT | 19 | 14 (73.7)a | 16 (84.2) | |
Early cancer/HGD | 12 | 8 (66.7) | 10 (83.3) | |
Neoplasia grade min/med | 4 | 3 (75.0) | 3 (75.0) | |
Other | 3 | 3 (100.0) | 3 (100.0) | |
Colon | SMT | 2 | 2 (100.0) | 2 (100.0) |
Fibroepithelioma | 1 | 1 (100.0) | 1 (100.0) | |
Leiomyoma | 1 | 1 (100.0) | 1 (100.0) | |
Non-SMT | 32 | 28 (87.5) | 29 (90.6) | |
Early cancer/HGD | 19 | 17 (89.5) | 17 (89.5) | |
Neoplasia grade min/med | 11 | 10 (90.9) | 10 (90.9) | |
Other | 2 | 1 (50.0) | 2 (100.0) |
P < 0.05 vs non-submucosal tumor (SMT). GIST: Gastrointestinal stromal tumor; HGD: High grade dysplasia.